NASDAQ : ICCM
IceCure Medical Ltd — Key statistics
Healthcare · Medical Devices · Israel
Last price 0.9567 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.44M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.04M |
| Enterprise Value | -7.91M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 4.64M |
| Shares Outstanding | 4.64M |
| Shares Change (YoY) | +35.73% |
| Shares Change (QoQ) | +25.86% |
| Owned by Insiders (%) | 26.43% |
| Owned by Institutions (%) | 2.84% |
| Float | 3.41M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| Forward PS | 0.76 |
| PB Ratio | 0.25 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.87 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -106.52 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -228.31% |
| Return on Assets (ROA) | -73.88% |
| Return on Invested Capital (ROIC) | -121.20% |
| Return on Capital Employed (ROCE) | -140.33% |
| Weighted Average Cost of Capital (WACC) | 9.48% |
| Revenue Per Employee | $57,203 |
| Profits Per Employee | -$244,638 |
| Employee Count | 69 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.03 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -96.12% |
| 50-Day Moving Average | 1.66 |
| 200-Day Moving Average | 7.92 |
| Relative Strength Index (RSI) | 18.18 |
| Average Volume (20 Days) | 156,217 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 42,182 |
| Short Previous Month | 52,159 |
| Short % of Shares Out | 0.91% |
| Short % of Float | 1.24% |
| Short Ratio (days to cover) | 0.24 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.95M |
| Gross Profit | 1.43M |
| Operating Income | -16.72M |
| Pretax Income | -16.88M |
| Net Income | -16.88M |
| EBITDA | -16.44M |
| EBIT | -16.72M |
| Loss Per Share | -$6.66 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 12.03M |
| Total Debt | 90,000 |
| Net Cash | 11.94M |
| Net Cash Per Share | $2.58 |
| Equity (Book Value) | 11.90M |
| Book Value Per Share | 3.47 |
| Working Capital | 10.86M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -15.87M |
| Capital Expenditures | -69,000 |
| Depreciation & Amortization | 284,000 |
| Net Borrowing | -2.00M |
| Free Cash Flow | -15.94M |
| FCF Per Share | -$3.44 |
Margins
| Measure | Value |
|---|
| Gross Margin | 36.10% |
| Operating Margin | -423.69% |
| Pretax Margin | -427.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -35.73% |
| Shareholder Yield | -35.73% |
| Earnings Yield | -765.34% |
| FCF Yield | -394.98% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $22.67 |
| Price Target Difference | 2,505.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 87.32% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 4, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.71 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |